Organogenesis Holdings Inc. (ORGO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+422.9%

$3.95

vs $0.76 price

Levered DCF

$0.64

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

1.23

Distress zone

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	32.38×	-450.7×	108.49×	22.42×	12.66×	47.06×	-10.93×	-10.8×
P/B	1.51×	1.09×	1.93×	1.32×	4.91×	5.72×	8.03×	14.88×
P/S	1.17×	0.87×	1.24×	0.78×	2.54×	2.4×	1.71×	3.62×
EV / EBITDA	9.41×	20.88×	15.31×	9.21×	13.84×	21.8×	-24.67×	-15.73×
Gross margin	75.6%	76.0%	75.4%	76.7%	75.6%	74.2%	70.9%	64.4%
Operating margin	9.9%	-0.3%	2.9%	4.9%	15.5%	7.9%	-11.4%	-26.7%
Net margin	6.6%	0.2%	1.1%	3.4%	20.2%	5.1%	-14.8%	-33.5%
Current ratio	3.62×	3.69×	2.8×	2.97×	2.74×	2.56×	2.1×	1.07×
Debt / equity	0.31×	0.11×	0.43×	0.47×	0.55×	0.6×	1.81×	1.26×
Interest coverage	0×	-0.83×	5.72×	11.1×	9.98×	2.37×	-3.32×	-4.75×
Dividend yield	0.0%	0.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	208.8%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	8.5%	0.2%	1.8%	5.8%	39.0%	12.2%	-69.6%	-137.8%
Return on invested capital	8.5%	0.1%	1.5%	4.4%	19.2%	10.7%	-18.2%	-50.5%
Return on assets	6.2%	0.2%	1.1%	3.5%	21.3%	5.9%	-17.5%	-39.6%
Free cash flow yield	-3.7%	1.0%	1.2%	-2.6%	2.6%	-1.5%	-8.9%	-8.9%
Earnings yield	5.6%	0.2%	0.9%	4.4%	7.9%	2.1%	-8.7%	-9.3%
Enterprise value	$695.7M	$329.1M	$551.7M	$371.2M	$1.2B	$811.6M	$487M	$738M
Net debt / EBITDA	0.53×	-5.85×	0.42×	0.53×	0.21×	0.01×	-2.05×	-0.81×
Cash conversion cycle (days)	135	75	61	46	51	80	29	33